C07C 233/45
Having the nitrogen atom of at least one of the carboxamide groups
Official title: having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
C07C233/45 (Having the nitrogen atom of at least one of the carboxamide groups) appears on 1,141 US grants and 999 published applications in this corpus.
Search patents in C07C- Granted patents
- 1,141
- Published applications
- 999
- Assignees
- 649
- Inventors
- 3,232
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 9 | 0 |
| 1977 | 8 | 0 |
| 1978 | 4 | 0 |
| 1979 | 3 | 0 |
| 1980 | 8 | 0 |
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 3 | 0 |
| 1984 | 6 | 0 |
| 1985 | 8 | 0 |
| 1986 | 1 | 0 |
| 1987 | 5 | 0 |
| 1988 | 2 | 0 |
| 1989 | 5 | 0 |
| 1990 | 11 | 0 |
| 1991 | 8 | 0 |
| 1992 | 19 | 0 |
| 1993 | 31 | 0 |
| 1994 | 26 | 0 |
| 1995 | 34 | 0 |
| 1996 | 28 | 0 |
| 1997 | 39 | 0 |
| 1998 | 44 | 0 |
| 1999 | 55 | 0 |
| 2000 | 41 | 0 |
| 2001 | 28 | 6 |
| 2002 | 39 | 45 |
| 2003 | 36 | 33 |
| 2004 | 14 | 53 |
| 2005 | 28 | 39 |
| 2006 | 28 | 37 |
| 2007 | 24 | 42 |
| 2008 | 19 | 32 |
| 2009 | 27 | 43 |
| 2010 | 20 | 42 |
| 2011 | 23 | 44 |
| 2012 | 34 | 43 |
| 2013 | 34 | 40 |
| 2014 | 47 | 43 |
| 2015 | 38 | 39 |
| 2016 | 32 | 45 |
| 2017 | 36 | 36 |
| 2018 | 26 | 42 |
| 2019 | 36 | 45 |
| 2020 | 43 | 61 |
| 2021 | 25 | 30 |
| 2022 | 27 | 34 |
| 2023 | 19 | 33 |
| 2024 | 27 | 28 |
| 2025 | 15 | 42 |
| 2026 | 15 | 22 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- N-acyl amino acid surfactants and derivatives thereof8 Sep 2026US 12,728,085 B2The Procter & Gamble Company
- Small molecules promoting sympathetic nerve regeneration8 Sep 2026US 12,729,177 B2Oregon Health & Science University
- Cinnamoyl amino acid compound and use thereof1 Sep 2026US 12,723,018 B2China Pharmaceutical University
- Branched-chain amino acid derivatives to treat disease25 Aug 2026US 12,715,839 B2Intrabio Ltd.
- Process for preparing a GIP/GLP1 dual agonist25 Aug 2026US 12,715,901 B2Eli Lilly and Company
- Improvements in or relating to organic compounds8 Oct 2026US 2026/0305664 A1Givaudan SA
- Method for quantitatively analyzing polysulfide in sample27 Aug 2026US 2026/0250239 A1Bio-Xcelerator, Inc.
- Synthetic derivatives of oleoyl-lysophosphatidylinositol (oleoyl-lpi) and uses thereof16 Jul 2026US 2026/0200837 A1Lipovexa Srl
- Cationic lipids and preparation method thereof16 Jul 2026US 2026/0200849 A1RiboX Therapeutics HK Limited
- Masp-2 inhibitors and methods of use9 Jul 2026US 2026/0193179 A9Omeros Corporation
Most cited
By later US patents
- Diketopiperazine-based delivery systems228US 5,976,569 AEmisphere Technologies, Inc. · 1999
- Acrylamido functional disubstituted acetyl aryl ketone photoinitiators213US 5,506,279 AMinnesota Mining and Manufacturing Company · 1996
- Targeted co-polymers for radiographic imaging210US 5,746,998 AThe General Hospital Corporation · 1998
- Biaryl substituted 4-amino-butyric acid amides190US 5,217,996 ACiba-Geigy Corporation · 1993
- Oral drug delivery compositions and methods186US 5,792,451 AEmisphere Technologies, Inc. · 1998